Maria Visalli

2.0k total citations
49 papers, 1.6k citations indexed

About

Maria Visalli is a scholar working on Molecular Biology, Immunology and Ophthalmology. According to data from OpenAlex, Maria Visalli has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 15 papers in Immunology and 8 papers in Ophthalmology. Recurrent topics in Maria Visalli's work include Epigenetics and DNA Methylation (10 papers), RNA Interference and Gene Delivery (5 papers) and Immunotherapy and Immune Responses (5 papers). Maria Visalli is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), RNA Interference and Gene Delivery (5 papers) and Immunotherapy and Immune Responses (5 papers). Maria Visalli collaborates with scholars based in Italy, United States and Chile. Maria Visalli's co-authors include Diana Teti, Isabella Venza, Mario Venza, Mario Venza, Rosaria Oteri, Concetta Beninati, N Mariano, David Landman, Steven E. Brooks and James J. Rahal and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Infectious Diseases and Biochemical and Biophysical Research Communications.

In The Last Decade

Maria Visalli

49 papers receiving 1.6k citations

Peers

Countries citing papers authored by Maria Visalli

Since Specialization

Citations

This map shows the geographic impact of Maria Visalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Visalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Visalli more than expected).

Fields of papers citing papers by Maria Visalli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Visalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Visalli. The network helps show where Maria Visalli may publish in the future.

Co-authorship network of co-authors of Maria Visalli

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Visalli. A scholar is included among the top collaborators of Maria Visalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Visalli. Maria Visalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ROS as Regulators of Cellular Processes in Melanoma 2021 ·Oxidative Medicine and Cellular Longevity ·Isabella Venza, Mario Venza, Maria Visalli, Germana Lentini, Diana Teti, Francesco Stagno d’Alcontres	37
2	microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors 2020 ·Cancer Treatment and Research Communications ·M. Aguennouz, Francesca Polito, Maria Visalli, Gian Luca Vita, Giovanni Raffa, Rosaria Oteri, Bouchra Ghazi, Gianluca Scalia, Filippo Flavio Angileri, Valeria Barresi, Maria Caffo, (unknown), Alfredo Conti, Vincenzo Macaione, (unknown), (unknown), Antonino Germanò	4
3	Genistein reduces proliferation of EP3-expressing melanoma cells through inhibition of PGE2-induced IL-8 expression 2018 ·International Immunopharmacology ·Isabella Venza, Maria Visalli, Rosaria Oteri, Concetta Beninati, Diana Teti, Mario Venza	29
4	Epidrugs in the Immunotherapy of Cutaneous and Uveal Melanoma 2017 ·Anti-Cancer Agents in Medicinal Chemistry ·Mario Venza, Maria Visalli, Teresa Catalano, Concetta Beninati, Diana Teti, Isabella Venza	9
5	Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis 2016 ·Anti-Cancer Agents in Medicinal Chemistry ·Mario Venza, Maria Visalli, Concetta Beninati, Carmelo Biondo, Diana Teti, (unknown)	7
6	DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma 2016 ·Oncology Reports ·Mario Venza, Maria Visalli, Teresa Catalano, Carmelo Biondo, Concetta Beninati, Diana Teti, Isabella Venza	38
7	miR-92a-3p and MYCBP2 are involved in MS-275-induced and c-myc-mediated TRAIL-sensitivity in melanoma cells 2016 ·International Immunopharmacology ·Mario Venza, Maria Visalli, Concetta Beninati, Salvatore Benfatto, Diana Teti, Isabella Venza	22
8	Epigenetic Effects of Cadmium in Cancer: Focus on Melanoma 2015 ·Current Genomics ·Mario Venza, Maria Visalli, Carmelo Biondo, Rosaria Oteri, (unknown), (unknown), Gerardo Caruso, Maria Caffo, Diana Teti, Isabella Venza	23
9	Involvement of epimutations in meningioma 2015 ·Brain Tumor Pathology ·Mario Venza, Maria Visalli, Concetta Beninati, Teresa Catalano, Carmelo Biondo, Diana Teti, Isabella Venza	6
10	Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP 2014 ·International Immunopharmacology ·Isabella Venza, Maria Visalli, Rosaria Oteri, Diana Teti, Mario Venza	39
11	Epigenetic regulation of p14 and p16 expression in cutaneous and uveal melanoma 2014 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Mario Venza, Maria Visalli, Carmelo Biondo, Maria Lentini, Teresa Catalano, Diana Teti, Isabella Venza	51
12	Association between oxidative stress and macromolecular damage in elderly patients with age-related macular degeneration 2012 ·Aging Clinical and Experimental Research ·Isabella Venza, Maria Visalli, Maria Cucinotta, Diana Teti, Mario Venza	26
13	PGE2 inducesinterleukin-8derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation 2012 ·Epigenetics ·Isabella Venza, Maria Visalli, (unknown), (unknown), (unknown), Maria Caffo, Gerardo Caruso, Concetta Alafaci, Francesco Tomasello, Diana Teti, Mario Venza	41
14	Contact Lens Wearing and Chronic Cigarette Smoking Positively Correlate with TGF-β₁and VEGF Tear Levels and Impaired Corneal Wound Healing After Photorefractive Keratectomy 2012 ·Current Eye Research ·Anna Maria Roszkowska, (unknown), Maria Visalli, Maurizio Mondello, Diana Teti, Mario Venza, Isabella Venza	14
15	MSX1 and TGF- 3 are novel target genes functionally regulated by FOXE1 2010 ·Human Molecular Genetics ·Isabella Venza, Maria Visalli, Luca Parrillo, Mario De Felice, (unknown), Mario Venza	39
16	Association of the DSS1 c.143G>A Polymorphism with Skin Squamous Cell Carcinoma 2010 ·Journal of Investigative Dermatology ·Mario Venza, Teresa Catalano, Maria Visalli, Isabella Venza, Maria Lentini, Maria Cristina Curia, Renato Mariani‐Costantini, Diana Teti	5
17	Changes in Inflammatory Mediators in Peri‐Implant Fluid After Implant Insertion 2009 ·Journal of Periodontology ·Mario Venza, Maria Visalli, Giuseppe Lo Giudice, Marco Cicciù, (unknown), Diana Teti	5
18	Altered binding of MYF‐5 toFOXE1promoter in non‐syndromic and CHARGE‐associated cleft palate 2008 ·Journal of Oral Pathology and Medicine ·Mario Venza, Maria Visalli, Isabella Venza, Claudia Torino, (unknown), (unknown), Diana Teti	14
19	FOXE1 gene mutation screening by multiplex PCR/DHPLC in CHARGE syndrome and syndromic and non-syndromic cleft palate 2006 ·Journal of Chromatography B ·Mario Venza, Maria Visalli, Isabella Venza, Claudia Torino, (unknown), Diana Teti	7
20	Age-related salivary polyamine increase in adolescents wearing orthodontic Ni-Ti archwires. 2002 ·Amino Acids ·Mario Venza, Maria Visalli, Paolo Ruggeri, D Cicciù, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact